Engineered microvessel networks -- Longitudinal transcriptomic profiling validates chip-grown tissues as a robust model for studying vasculature
Vascularised Organ-on-Chip (OoC) models are promising New Approach Methodologies (NAMs), but their translation requires validation for defined Contexts of Use (CoU). Here, we combine microfluidic microvessel networks (MVNs) with longitudinal bulk and single-cell RNA sequencing to determine how cell provenance influences engineered vascular phenotype. Stromal cell identity produced distinct…
Engineered microvessel networks (MVNs) are a new approach for studying vascular systems, with the potential to become a valuable New Approach Methodology (NAM). However, before their widespread use, it is crucial to validate these models under defined contexts of use (CoU). In this study, researchers used microfluidic MVNs in conjunction with longitudinal bulk and single-cell RNA sequencing to investigate how cell origin impacts the vascular phenotype of these engineered tissues.
The researchers discovered that stromal cell identity plays a significant role in determining the architecture and transcriptional trajectory of the MVNs. Although stromal cells are often considered interchangeable, the study revealed that they are crucial factors that influence the performance of these microvascular models.
In their experiments, primary human pancreatic microvascular endothelial cells struggled to form stable perfusable networks. However, adding 10% Human Umbilical Vein Endothelial Cells (HUVECs) or Blood Outgrowth Endothelial Cells (BOECs) successfully rescued the self-assembly of these networks. Through single-cell transcriptomics, the researchers identified specialized endothelial populations involved in vascular morphogenesis, such as tip, stalk, phalanx, endothelial to mesenchymal transition (EndMT), and pericyte-like endothelial cells.
Interestingly, MVNs that failed to develop coherent endothelial specialization lacked the stability of properly formed networks. Conversely, rescued networks exhibited stabilized cell states and revealed FLRT2--UNC5B signalling within pericyte-like HUVECs. This specific signalling pathway is known to be involved in angiogenic development in vivo.
These findings demonstrate that cell provenance is a critical determinant of microvascular NAM performance. By validating MVNs through transcriptomic analyses, researchers can define and strengthen the biological relevance of these microvessel-on-chip models for specific CoUs. This approach will undoubtedly contribute to the advancement of in vitro models for understanding vascular systems and their diseases.
Rewritten by urgent.news; may contain errors — check the original.
